3-MeO-PCE or 3-methoxy Eticyclidine is a new designer drug dissociative, a structural analogue of 3-MeO-PCP. 3-MeO-PCE is an NMDA receptor antagonist that inhibits signaling between neurons, which leads to dissociation, which is characteristic of arylcyclohexylamine substances. 3-MeO-PCE is a stronger substance than 3-MeO-PCP and requires a lower dosage for chemical studies not exceeding 20 milligrams. 3-MeO-PCE is produced in modern laboratory in compliance with all standards, which makes it the highest quality.